Regeneron Pharmaceuticals, Inc. Fourth quarter 2025 revenues increased 3% to $3.9 billion versus fourth quarter 2024; full year 2025 revenues increased 1% to $14.3 billion versus ...
Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on advancing precision cardiorenal care in critical care settings, today announced that ...
18h
Proposals of the Shareholders' Nomination Board of Bioretec Ltd to the Annual General Meeting 2026
Bioretec Ltd Company announcement 30 January 2026 at 1.45 p.m EETTAMPERE, Finland, Jan. 30, 2026 /PRNewswire/ -- The Shareholders' Nomination Board of Bioretec Ltd ("Bioretec") has resolved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results